Alivus Life Sciences (NSE:ALIVUS) Inventories, Raw Materials & Components: ₹0 Mil (As of Mar. 2026)


NSE:ALIVUS Alivus Life Sciences Ltd NSE:ALIVUS
83 GF Score
Price ₹1,157.70
GF Value ₹1,006.16
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Alivus Life Sciences Inventories, Raw Materials & Components?

Alivus Life Sciences NSE:ALIVUS -0.13% 83 Inventories, Raw Materials & Components is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:ALIVUS with a GF Score™ of 83/100 and a GF Value™ of ₹1,006.16 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Alivus Life Sciences's inventories, raw materials & components for the quarter that ended in Mar. 2026 was ₹0 Mil.

Alivus Life Sciences's annual raw materials increased from Mar. 2024 (₹1,887 Mil) to Mar. 2025 (₹2,229 Mil) but then declined from Mar. 2025 (₹2,229 Mil) to Mar. 2026 (₹0 Mil).

Alivus Life Sciences Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Alivus Life Sciences's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alivus Life Sciences Inventories, Raw Materials & Components Chart

Alivus Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 1,793.52 1,828.80 1,886.52 2,229.08 0.00

Alivus Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,229.08 0.00 0.00 0.00 0.00
NSE:ALIVUS
83GF Score
Alivus Life Sciences Ltd NSE:ALIVUS
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alivus Life Sciences Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ₹0 Mil mean?
Alivus Life Sciences (NSE:ALIVUS) has a Inventories, Raw Materials & Components of ₹0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Alivus Life Sciences and its competitors.
Is Alivus Life Sciences' Inventories, Raw Materials & Components too high?
Alivus Life Sciences' current Inventories, Raw Materials & Components is ₹0 Mil. Overall, Alivus Life Sciences has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alivus Life Sciences' Inventories, Raw Materials & Components compare to ZTS and UTHR?
Alivus Life Sciences' Inventories, Raw Materials & Components of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Alivus Life Sciences and its competitors. Alivus Life Sciences's current Inventories, Raw Materials & Components is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alivus Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Alivus Life Sciences (NSE:ALIVUS) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,006.16, compared to a current price of ₹1,157.70 — trading 15.1% above its estimated fair value. The current Inventories, Raw Materials & Components is ₹0 Mil. Alivus Life Sciences' overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Alivus Life Sciences (NSE:ALIVUS), the current Inventories, Raw Materials & Components is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alivus Life Sciences (NSE:ALIVUS) Overvalued in 2026?

Based on GuruFocus' analysis, Alivus Life Sciences stock appears to be overvalued. The current stock price of ₹1,157.70 is trading 15.1% above its estimated GF Value™ of ₹1,006.16. GuruFocus considers Alivus Life Sciences to be Modestly Overvalued.

Key valuation signals for NSE:ALIVUS:

  • Inventories, Raw Materials & Components: ₹0 Mil
  • GF Value™: ₹1,006.16 vs. price of ₹1,157.70 (15.1% above fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the NSE:ALIVUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alivus Life Sciences Business Description

Other Exchanges 543322:India
Address 470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099
Alivus Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disorders, pain management, diabetes, urology, gastrointestinal disorders, and other therapeutic areas.
83GF Score

Get the complete analysis for NSE:ALIVUS

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,157.70
Price
₹1,006.16
GF Value